127 related articles for article (PubMed ID: 11921428)
1. The evolving role of oral insulin in the treatment of diabetes using a novel RapidMist System.
Modi P; Mihic M; Lewin A
Diabetes Metab Res Rev; 2002; 18 Suppl 1():S38-42. PubMed ID: 11921428
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of addition of oral spray insulin (Oralin) on insulin secretion and metabolic control in subjects with type 2 diabetes mellitus suboptimally controlled on oral hypoglycemic agents.
Guevara-Aguirre J; Guevara M; Saavedra J; Mihic M; Modi P
Diabetes Technol Ther; 2004 Feb; 6(1):1-8. PubMed ID: 15000763
[TBL] [Abstract][Full Text] [Related]
3. Review of clinical trials: update on oral insulin spray formulation.
Pozzilli P; Raskin P; Parkin CG
Diabetes Obes Metab; 2010 Feb; 12(2):91-6. PubMed ID: 19889002
[TBL] [Abstract][Full Text] [Related]
4. Oral spray insulin in treatment of type 2 diabetes: a comparison of efficacy of the oral spray insulin (Oralin) with subcutaneous (SC) insulin injection, a proof of concept study.
Guevara-Aguirre J; Guevara M; Saavedra J; Mihic M; Modi P
Diabetes Metab Res Rev; 2004; 20(6):472-8. PubMed ID: 15386822
[TBL] [Abstract][Full Text] [Related]
5. Development of oral insulin: progress and current status.
Gordon Still J
Diabetes Metab Res Rev; 2002; 18 Suppl 1():S29-37. PubMed ID: 11921427
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures.
Roach P; Woodworth JR
Clin Pharmacokinet; 2002; 41(13):1043-57. PubMed ID: 12403642
[TBL] [Abstract][Full Text] [Related]
7. Insulin therapy in type 2 diabetes.
Mudaliar S; Edelman SV
Endocrinol Metab Clin North Am; 2001 Dec; 30(4):935-82. PubMed ID: 11727406
[TBL] [Abstract][Full Text] [Related]
8. Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus.
Pham DQ; Cohen H; Chu V
J Clin Pharmacol; 2007 Jul; 47(7):890-903. PubMed ID: 17585117
[TBL] [Abstract][Full Text] [Related]
9. The Barmer study: impact of standardized warming of the injection site to enhance insulin absorption and reduce prandial insulin requirements and hypoglycemia in obese patients with diabetes mellitus.
Pfützner A; Hermanns N; Funke K; Forst T; Behnke T; Bitton G; Nagar R; Raz I; Haak T
Curr Med Res Opin; 2014 May; 30(5):753-60. PubMed ID: 24392996
[TBL] [Abstract][Full Text] [Related]
10. Buccal spray insulin (Oralgen) for type 2 diabetes: what evidence?
Palermo A; Maddaloni E; Pozzilli P
Expert Opin Biol Ther; 2012 Jun; 12(6):767-72. PubMed ID: 22515262
[TBL] [Abstract][Full Text] [Related]
11. Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique.
Cernea S; Kidron M; Wohlgelernter J; Modi P; Raz I
Clin Ther; 2004 Dec; 26(12):2084-91. PubMed ID: 15823772
[TBL] [Abstract][Full Text] [Related]
12. Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes.
Kipnes M; Dandona P; Tripathy D; Still JG; Kosutic G
Diabetes Care; 2003 Feb; 26(2):421-6. PubMed ID: 12547873
[TBL] [Abstract][Full Text] [Related]
13. Recent Updates on Novel Approaches in Insulin Drug Delivery: A Review of Challenges and Pharmaceutical Implications.
Pandey M; Choudhury H; Yi CX; Mun CW; Phing GK; Rou GX; Singh BJKAAJ; Jhee ANA; Chin LK; Kesharwani P; Gorain B; Hussain Z
Curr Drug Targets; 2018; 19(15):1782-1800. PubMed ID: 29792143
[TBL] [Abstract][Full Text] [Related]
14. Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats.
Morishita M; Goto T; Nakamura K; Lowman AM; Takayama K; Peppas NA
J Control Release; 2006 Feb; 110(3):587-94. PubMed ID: 16325951
[TBL] [Abstract][Full Text] [Related]
15. Repaglinide--prandial glucose regulator: a new class of oral antidiabetic drugs.
Owens DR
Diabet Med; 1998; 15 Suppl 4():S28-36. PubMed ID: 9868989
[TBL] [Abstract][Full Text] [Related]
16. Improved insulin absorption by means of standardized injection site modulation results in a safer and more efficient prandial insulin treatment. A review of the existing clinical data.
Pfützner A; Raz I; Bitton G; Klonoff D; Nagar R; Hermanns N; Haak T
J Diabetes Sci Technol; 2015 Jan; 9(1):116-22. PubMed ID: 25352633
[TBL] [Abstract][Full Text] [Related]
17. Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure.
Kokić S; Buković D; Radman M; Capkun V; Gabrić N; Lesko V; Karelović D; Stancerić T
Coll Antropol; 2003 Jun; 27(1):181-7. PubMed ID: 12974145
[TBL] [Abstract][Full Text] [Related]
18. Insulin 70/30 mix plus metformin versus triple oral therapy in the treatment of type 2 diabetes after failure of two oral drugs: efficacy, safety, and cost analysis.
Schwartz S; Sievers R; Strange P; Lyness WH; Hollander P;
Diabetes Care; 2003 Aug; 26(8):2238-43. PubMed ID: 12882842
[TBL] [Abstract][Full Text] [Related]
19. Software-guided insulin dosing improves intrapartum glycemic management in women with diabetes mellitus.
Dinglas C; Muscat J; Adams T; Peragallo-Dittko V; Vintzileos A; Heo HJ
Am J Obstet Gynecol; 2018 Aug; 219(2):191.e1-191.e6. PubMed ID: 29750952
[TBL] [Abstract][Full Text] [Related]
20. Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes.
Pettis RJ; Hirsch L; Kapitza C; Nosek L; Hövelmann U; Kurth HJ; Sutter DE; Harvey NG; Heinemann L
Diabetes Technol Ther; 2011 Apr; 13(4):443-50. PubMed ID: 21355716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
